glioblastoma-multiforme-market

Glioblastoma Multiforme Market By Drug Type (Bevacizumab, Temozolomide, Carmustine) - Growth, Share, Opportunities & Competitive Analysis, 2021 - 2029

08 Jun 2016 Format PDF icon PPT icon XLS icon Request Sample
Choose Licence Type
$4325
$6325
$8325
Why Acute
View Other Reports